Singapore-based CellResearch Corporation (CellResearchCorp), a biotechnology firm specialising in stem cell research aimed at wound treatments, is considering a listing on the New York-based Nasdaq in 2019 as part of its plans to establish a global footprint.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
